HWMZX | MVCAX | HWMZX / MVCAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 5 years | 23 years | - |
Gain YTD | 6.507 | 17.801 | 37% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 437M | 17.9B | 2% |
Annual Yield % from dividends | 0.38 | 1.16 | 33% |
Returns for 1 year | 17.57 | 26.84 | 65% |
Returns for 3 years | 28.13 | 8.55 | 329% |
Returns for 5 years | 87.49 | 49.25 | 178% |
Returns for 10 years | N/A | 78.64 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WFEFX | 12.46 | -0.06 | -0.48% |
Allspring International Equity C | |||
LIFLX | 14.31 | -0.09 | -0.62% |
Lord Abbett Focused Large Cap Value I | |||
PJFPX | 73.02 | -1.65 | -2.21% |
PGIM Jennison Growth R4 | |||
SSTFX | 13.62 | -0.33 | -2.37% |
Virtus KAR Capital Growth C | |||
FBTTX | 27.34 | -1.40 | -4.87% |
Fidelity Advisor Biotechnology M |